12804399

Source:http://linkedlifedata.com/resource/pubmed/id/12804399

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0038525, umls-concept:C0087111
pubmed:issue	2
pubmed:dateCreated	2003-6-13
pubmed:abstractText	Rebleeding is an important cause of death and disability in people with aneurysmal subarachnoid haemorrhage. Rebleeding is probably due to dissolution of the clot by natural fibrinolytic activity.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12804399-10796425
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100909747
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antifibrinolytic Agents
pubmed:status	MEDLINE
pubmed:issn	1469-493X
pubmed:author	pubmed-author:AlgraAA, pubmed-author:RinkelG J EGJ, pubmed-author:RoosY B W E MYB, pubmed-author:VermeulenMM, pubmed-author:van GijnJJ
pubmed:issnType	Electronic
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	CD001245
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12804399-Administration, Oral, pubmed-meshheading:12804399-Antifibrinolytic Agents, pubmed-meshheading:12804399-Confidence Intervals, pubmed-meshheading:12804399-Humans, pubmed-meshheading:12804399-Injections, Intravenous, pubmed-meshheading:12804399-Randomized Controlled Trials as Topic, pubmed-meshheading:12804399-Subarachnoid Hemorrhage, pubmed-meshheading:12804399-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
pubmed:affiliation	Dept. of Neurology, Academic Medical Center, Meibergdreef 9, Amsterdam, Netherlands. y.b.roos@amc.uva.nl
pubmed:publicationType	Journal Article, Review